IP Library › Granted Patent US 8,912,205
Granted Patent B2
US 8,912,205 · App. 13/943,049 · Granted Dec 16, 2014

Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,912,205
App. No.
13/943,049
Granted
Dec 16, 2014
Kind
B2
Abstract

A pharmaceutical formulation comprising the compound of formula

Claims (5)

1. A pharmaceutical formulation presented in unit dose form comprising

the compound of formula

as an active ingredient,

wherein said active ingredient s present within said unit dose form in an amount from 70 mg to 700 mg.

2. The formulation of claim 1 , wherein said unit dose is a tablet.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2015
From: LEO OSPREY LIMITED
To: NOVARTIS AG
Reel/Frame 035771/0154 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2015
From: GLAXOSMITHKLINE LLC
To: LEO OSPREY LIMITED
Reel/Frame 035762/0741 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NUMBER 13394049 PREVIOUSLY RECORDED ON REEL 031739 FRAME 0287. ASSIGNOR(S) HEREBY CONFIRMS THE APPLICATION NUMBER SHOULD READ 13943049. Recorded Dec 17, 2013
From: LACKEY, KAREN ELIZABETH; CARTER, MALCOLM CLIVE; COCKERILL, GEORGE STUART
To: GLAXOSMITHKLINE LLC
Reel/Frame 031831/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2013
From: LACKEY, KAREN ELIZABETH; CARTER, MALCOLM CLIVE; COCKERILL, GEORGE STUART
To: GLAXOSMITHKLINE LLC
Reel/Frame 031739/0287 →